Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.
Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Softic L, Chollet L, Trémeaux P, Imbert-Marcille BM, Pillet S, Veyrenche N, Boudet A, Deroche L, Burrel S, Mouna L, Cocherie T, Schnuriger A, Pronier C, Handala L, Brodard V, Gallais F, Larrat S, Regueme A, Dossou NC, Henry A, Gault E, Hartard C, Brichler S, Moisan A, Avettand-Fenoel V, Lefeuvre C, Engelmann I, Castelain S, Mirand A, Salmona M, Jaffar-Bandjee MC, Ader M, Seng S, Cappy P, Rodriguez C, Ly A, Dos Santos G, Schwartz O, Petiot C, Planas D, Ibraim SB, Da Silva K, Recoing A, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA; POLYRES investigators.
Fourati S, et al. Among authors: henry a.
Lancet Microbe. 2026 Jun 2:101353. doi: 10.1016/j.lanmic.2026.101353. Online ahead of print.
Lancet Microbe. 2026.
PMID: 42229496
Free article.